| Min Pa: | Min Pa(max): | Activity's type: |
| Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |
|---|---|---|---|---|---|---|
| 0.731 | 0.025 | 0.836 | Antiinflammatory | 0.721 0.027 CID_10446031 0.836 0.011 CID_101649831 | CID_101649831 | |
| 0.701 | 0.008 | 0.866 | Cholesterol antagonist | 0.778 0.004 CID_10446031 0.866 0.003 CID_101649831 | CID_101649831 | |
| 0.679 | 0.004 | 0.679 | Anesthetic general | 0.241 0.054 CID_10446031 0.609 0.004 CID_101649831 | ||
| 0.673 | 0.007 | 0.77 | Antioxidant | 0.668 0.007 CID_10446031 0.77 0.005 CID_101649831 | CID_101649831 | |
| 0.663 | 0.005 | 0.663 | Hypolipemic | 0.458 0.016 CID_10446031 0.573 0.008 CID_101649831 | ||
| 0.664 | 0.011 | 0.664 | Aldehyde oxidase inhibitor | |||
| 0.624 | 0.004 | 0.624 | Peroxidase inhibitor | 0.387 0.022 CID_10446031 | ||
| 0.596 | 0.009 | 0.689 | Free radical scavenger | 0.406 0.028 CID_10446031 0.689 0.005 CID_101649831 | CID_101649831 | |
| 0.569 | 0.004 | 0.569 | Lipid peroxidase inhibitor | 0.45 0.007 CID_10446031 0.461 0.007 CID_101649831 | ||
| 0.566 | 0.003 | 0.566 | Vanilloid agonist | 0.383 0.004 CID_10446031 0.205 0.006 CID_101649831 | ||
| 0.585 | 0.038 | 0.666 | Caspase 9 stimulant | 0.666 0.028 CID_101649831 | CID_101649831 | |
| 0.593 | 0.05 | 0.691 | Apoptosis agonist | 0.311 0.165 CID_10446031 0.691 0.032 CID_101649831 | CID_101649831 | |
| 0.547 | 0.015 | 0.607 | Apoptosis antagonist | 0.22 0.156 CID_10446031 0.607 0.009 CID_101649831 | CID_101649831 | |
| 0.542 | 0.018 | 0.656 | Histamine release inhibitor | 0.491 0.032 CID_10446031 0.656 0.006 CID_101649831 | CID_101649831 | |
| 0.538 | 0.017 | 0.538 | GABA C receptor rho-3 antagonist | |||
| 0.524 | 0.003 | 0.524 | TRPA1 agonist | 0.431 0.004 CID_10446031 0.282 0.005 CID_101649831 | ||
| 0.513 | 0.025 | 0.528 | Vasodilator, peripheral | 0.528 0.023 CID_101649831 | CID_101649831 | |
| 0.486 | 0.004 | 0.486 | Neurotrophic factor enhancer | 0.197 0.079 CID_10446031 0.475 0.004 CID_101649831 | ||
| 0.493 | 0.014 | 0.624 | Superoxide dismutase inhibitor | 0.624 0.006 CID_10446031 | CID_10446031 | |
| 0.479 | 0.005 | 0.479 | 5-Lipoxygenase inhibitor | |||
| 0.502 | 0.032 | 0.555 | 5 Hydroxytryptamine release inhibitor | 0.555 0.018 CID_101649831 | CID_101649831 | |
| 0.496 | 0.028 | 0.496 | 5 Hydroxytryptamine release stimulant | 0.379 0.05 CID_101649831 | ||
| 0.473 | 0.008 | 0.643 | Melanin inhibitor | 0.159 0.071 CID_10446031 0.643 0.004 CID_101649831 | CID_101649831 | |
| 0.477 | 0.022 | 0.477 | Lipoxygenase inhibitor | 0.214 0.127 CID_10446031 | ||
| 0.475 | 0.023 | 0.475 | Glucose-6-phosphate dehydrogenase-6-phosphogluconolactonase inhibitor | 0.149 0.144 CID_10446031 | ||
| 0.456 | 0.005 | 0.456 | Cyclooxygenase 1 inhibitor | 0.37 0.009 CID_10446031 0.143 0.061 CID_101649831 | ||
| 0.452 | 0.005 | 0.452 | Tyrosine 3 hydroxylase inhibitor | 0.231 0.089 CID_10446031 | ||
| 0.489 | 0.046 | 0.778 | Transcription factor NF kappa B inhibitor | 0.318 0.086 CID_10446031 0.778 0.014 CID_101649831 | CID_101649831 | |
| 0.444 | 0.01 | 0.712 | Monophenol monooxygenase inhibitor | 0.28 0.02 CID_10446031 0.712 0.004 CID_101649831 | CID_101649831 | |
| 0.425 | 0.011 | 0.425 | Sodium/bile acid cotransporter inhibitor | 0.387 0.021 CID_10446031 0.344 0.044 CID_101649831 | ||
| 0.43 | 0.032 | 0.43 | 12-Lipoxygenase inhibitor | |||
| 0.39 | 0.002 | 0.39 | Thyroid hormone alpha antagonist | 0.048 0.004 CID_10446031 0.034 0.005 CID_101649831 | ||
| 0.392 | 0.005 | 0.392 | Heat shock protein 90 alpha antagonist | 0.126 0.118 CID_101649831 | ||
| 0.452 | 0.066 | 0.829 | Cyclophilin D inhibitor | 0.485 0.055 CID_10446031 0.829 0.005 CID_101649831 | CID_101649831 | |
| 0.398 | 0.014 | 0.398 | 5 Hydroxytryptamine uptake stimulant | 0.199 0.154 CID_10446031 | ||
| 0.438 | 0.058 | 0.438 | 15-Lipoxygenase inhibitor | 0.364 0.091 CID_10446031 | ||
| 0.388 | 0.011 | 0.454 | Phospholipase C inhibitor | 0.454 0.008 CID_10446031 0.227 0.031 CID_101649831 | CID_10446031 | |
| 0.386 | 0.01 | 0.567 | Alpha-N-acetylglucosaminidase inhibitor | 0.126 0.072 CID_10446031 0.567 0.004 CID_101649831 | CID_101649831 | |
| 0.366 | 0.005 | 0.366 | Heat shock protein 90 antagonist | 0.21 0.033 CID_101649831 | ||
| 0.389 | 0.029 | 0.389 | Calcium channel activator | 0.233 0.168 CID_10446031 | ||
| 0.375 | 0.016 | 0.541 | Non-steroidal antiinflammatory agent | 0.204 0.068 CID_10446031 0.541 0.005 CID_101649831 | CID_101649831 | |
| 0.377 | 0.021 | 0.473 | RNA-directed DNA polymerase inhibitor | 0.473 0.012 CID_10446031 0.41 0.017 CID_101649831 | CID_10446031 | |
| 0.352 | 0.003 | 0.352 | Acetyl-CoA transferase inhibitor | 0.117 0.009 CID_10446031 0.085 0.018 CID_101649831 | ||
| 0.405 | 0.06 | 0.548 | Immunosuppressant | 0.308 0.11 CID_10446031 0.548 0.021 CID_101649831 | CID_101649831 | |
| 0.34 | 0.004 | 0.34 | Vanilloid 1 agonist | 0.255 0.005 CID_10446031 0.272 0.005 CID_101649831 | ||
| 0.391 | 0.058 | 0.391 | Thyroid hormone antagonist | |||
| 0.375 | 0.044 | 0.565 | Vasodilator, coronary | 0.565 0.009 CID_101649831 | CID_101649831 | |
| 0.361 | 0.032 | 0.361 | Amyloid beta aggregation inhibitor | 0.211 0.072 CID_101649831 | ||
| 0.331 | 0.005 | 0.331 | Estrogen receptor beta antagonist | 0.115 0.039 CID_10446031 | ||
| 0.37 | 0.047 | 0.514 | Spasmolytic | 0.31 0.066 CID_10446031 0.514 0.021 CID_101649831 | CID_101649831 | |
| 0.324 | 0.002 | 0.324 | Purinergic P2X2 antagonist | 0.263 0.003 CID_10446031 0.202 0.005 CID_101649831 | ||
| 0.402 | 0.08 | 0.402 | Calcium channel L-type activator | |||
| 0.358 | 0.037 | 0.436 | Antiamyloidogenic | 0.152 0.145 CID_10446031 0.436 0.023 CID_101649831 | CID_101649831 | |
| 0.334 | 0.016 | 0.514 | Interferon gamma antagonist | 0.137 0.098 CID_10446031 0.514 0.005 CID_101649831 | CID_101649831 | |
| 0.355 | 0.037 | 0.703 | Hypoglycemic | 0.703 0.005 CID_101649831 | CID_101649831 | |
| 0.36 | 0.042 | 0.36 | Hypoxia-inducible factor 1 alpha inhibitor | 0.356 0.043 CID_101649831 | ||
| 0.323 | 0.005 | 0.323 | Estrogen antagonist | 0.119 0.056 CID_10446031 0.124 0.047 CID_101649831 | ||
| 0.325 | 0.017 | 0.325 | Glyceraldehyde-3-phosphate dehydrogenase inhibitor | 0.256 0.04 CID_101649831 | ||
| 0.339 | 0.033 | 0.533 | Nitric oxide antagonist | 0.209 0.064 CID_10446031 0.533 0.014 CID_101649831 | CID_101649831 | |
| 0.388 | 0.082 | 0.673 | Antibacterial | 0.529 0.033 CID_10446031 0.673 0.011 CID_101649831 | CID_101649831 | |
| 0.316 | 0.016 | 0.62 | Amylase inhibitor | 0.62 0.004 CID_101649831 | CID_101649831 | |
| 0.313 | 0.016 | 0.313 | Cyclooxygenase inhibitor | 0.212 0.037 CID_10446031 | ||
| 0.309 | 0.011 | 0.325 | NADPH oxidase inhibitor | 0.325 0.009 CID_101649831 | CID_101649831 | |
| 0.34 | 0.05 | 0.484 | Interleukin 2 agonist | 0.484 0.01 CID_101649831 | CID_101649831 | |
| 0.351 | 0.068 | 0.351 | Thyroid hormone beta antagonist | |||
| 0.363 | 0.08 | 0.363 | Calpain 2 inhibitor | |||
| 0.281 | 0.003 | 0.281 | GABA B receptor agonist | 0.13 0.005 CID_10446031 0.074 0.058 CID_101649831 | ||
| 0.283 | 0.005 | 0.283 | Alcohol oxidase inhibitor | 0.058 0.037 CID_101649831 | ||
| 0.279 | 0.003 | 0.279 | Glycine receptor agonist | 0.189 0.004 CID_10446031 0.229 0.004 CID_101649831 | ||
| 0.338 | 0.066 | 0.338 | Streptokinase A inhibitor | |||
| 0.282 | 0.011 | 0.282 | Cystathionine beta-synthase inhibitor | 0.276 0.012 CID_101649831 | ||
| 0.271 | 0.001 | 0.271 | Thyroid hormone alpha agonist | 0.047 0.003 CID_10446031 0.032 0.004 CID_101649831 | ||
| 0.286 | 0.019 | 0.483 | Protein kinase stimulant | 0.483 0.004 CID_101649831 | CID_101649831 | |
| 0.274 | 0.008 | 0.274 | Farnesoid X receptor antagonist | 0.146 0.057 CID_10446031 0.13 0.083 CID_101649831 | ||
| 0.278 | 0.014 | 0.329 | Cholesterol synthesis inhibitor | 0.329 0.009 CID_10446031 0.175 0.034 CID_101649831 | CID_10446031 | |
| 0.275 | 0.011 | 0.275 | GABA C receptor agonist | |||
| 0.294 | 0.031 | 0.574 | Hepatoprotectant | 0.31 0.027 CID_10446031 0.574 0.005 CID_101649831 | CID_101649831 | |
| 0.277 | 0.015 | 0.277 | Succinate dehydrogenase inhibitor | 0.205 0.045 CID_10446031 0.142 0.129 CID_101649831 | ||
| 0.279 | 0.017 | 0.305 | Nitric-oxide synthase stimulant | 0.305 0.01 CID_101649831 | CID_101649831 | |
| 0.305 | 0.046 | 0.454 | Interleukin agonist | 0.454 0.012 CID_101649831 | CID_101649831 | |
| 0.304 | 0.048 | 0.828 | Angiogenesis stimulant | 0.628 0.005 CID_10446031 0.828 0.003 CID_101649831 | CID_101649831 | |
| 0.262 | 0.006 | 0.453 | Estrogen agonist | 0.453 0.004 CID_10446031 0.132 0.013 CID_101649831 | CID_10446031 | |
| 0.256 | 0.006 | 0.256 | GABA C receptor antagonist | 0.174 0.019 CID_10446031 | ||
| 0.272 | 0.022 | 0.409 | NOS3 expression enhancer | 0.409 0.008 CID_101649831 | CID_101649831 | |
| 0.245 | 0.004 | 0.245 | Prolactin inhibitor | 0.082 0.078 CID_10446031 | ||
| 0.249 | 0.014 | 0.436 | ATPase inhibitor | 0.436 0.003 CID_101649831 | CID_101649831 | |
| 0.252 | 0.019 | 0.252 | Anesthetic local | |||
| 0.237 | 0.006 | 0.237 | Creatine kinase inhibitor | 0.124 0.038 CID_10446031 | ||
| 0.238 | 0.009 | 0.238 | Arachidonic acid antagonist | 0.203 0.03 CID_10446031 0.178 0.056 CID_101649831 | ||
| 0.249 | 0.022 | 0.249 | Nav1.2 sodium channel blocker | 0.227 0.026 CID_10446031 | ||
| 0.277 | 0.051 | 0.405 | Cyclic AMP phosphodiesterase inhibitor | 0.405 0.016 CID_101649831 | CID_101649831 | |
| 0.275 | 0.054 | 0.275 | Interleukin antagonist | |||
| 0.274 | 0.054 | 0.274 | Gastrin inhibitor | 0.215 0.126 CID_101649831 | ||
| 0.221 | 0.007 | 0.221 | Adenylate cyclase stimulant | 0.211 0.009 CID_10446031 0.157 0.053 CID_101649831 | ||
| 0.233 | 0.019 | 0.233 | Chelator | 0.092 0.09 CID_101649831 | ||
| 0.3 | 0.088 | 0.704 | Antithrombotic | 0.53 0.025 CID_10446031 0.704 0.008 CID_101649831 | CID_101649831 | |
| 0.215 | 0.007 | 0.215 | Keratolytic | 0.07 0.064 CID_101649831 | ||
| 0.224 | 0.019 | 0.242 | Mannose-6-phosphate isomerase inhibitor | 0.242 0.014 CID_101649831 | CID_101649831 | |
| 0.263 | 0.059 | 0.416 | DNA synthesis inhibitor | 0.171 0.167 CID_10446031 0.416 0.02 CID_101649831 | CID_101649831 | |
| 0.213 | 0.011 | 0.213 | Porphobilinogen synthase inhibitor | 0.107 0.033 CID_10446031 | ||
| 0.206 | 0.004 | 0.206 | Heat shock protein 90 beta antagonist | |||
| 0.249 | 0.049 | 0.364 | DNA methylase inhibitor | 0.364 0.015 CID_101649831 | CID_101649831 | |
| 0.212 | 0.016 | 0.226 | Nav1.4 sodium channel blocker | 0.226 0.013 CID_10446031 | CID_10446031 | |
| 0.211 | 0.017 | 0.419 | UDP-glucose 4-epimerase inhibitor | 0.419 0.005 CID_101649831 | CID_101649831 | |
| 0.197 | 0.003 | 0.197 | Estrogen-related receptor beta agonist | 0.098 0.027 CID_10446031 0.088 0.044 CID_101649831 | ||
| 0.21 | 0.016 | 0.21 | GABA receptor agonist | |||
| 0.23 | 0.036 | 0.491 | Protein-tyrosine phosphatase inhibitor | 0.491 0.005 CID_10446031 0.177 0.058 CID_101649831 | CID_10446031 | |
| 0.218 | 0.024 | 0.345 | Protein-tyrosine phosphatase 1B inhibitor | 0.345 0.008 CID_10446031 0.184 0.034 CID_101649831 | CID_10446031 | |
| 0.268 | 0.075 | 0.268 | Transcription factor STAT inhibitor | |||
| 0.271 | 0.079 | 0.271 | Insulysin inhibitor | |||
| 0.233 | 0.042 | 0.233 | Mcl-1 antagonist | |||
| 0.264 | 0.073 | 0.327 | DNA damaging | 0.327 0.048 CID_101649831 | CID_101649831 | |
| 0.345 | 0.156 | 0.345 | Ca2+/calmodulin-dependent protein kinase kinase A inhibitor | |||
| 0.196 | 0.007 | 0.196 | DOPA decarboxylase inhibitor | |||
| 0.205 | 0.017 | 0.566 | Cyclooxygenase 3 inhibitor | 0.566 0.003 CID_101649831 | CID_101649831 | |
| 0.2 | 0.013 | 0.2 | Mucolytic | 0.116 0.058 CID_10446031 0.198 0.014 CID_101649831 | ||
| 0.195 | 0.011 | 0.525 | Triose-phosphate isomerase inhibitor | 0.525 0.002 CID_10446031 0.364 0.004 CID_101649831 | CID_10446031 | |
| 0.196 | 0.013 | 0.196 | HIV-1 integrase (Overall Integration) inhibitor | 0.136 0.031 CID_10446031 | ||
| 0.192 | 0.01 | 0.192 | Sphingosine 1-phosphate receptor 2 antagonist | 0.122 0.093 CID_10446031 | ||
| 0.2 | 0.018 | 0.2 | Ca2+/calmodulin-dependent protein kinase kinase B inhibitor | |||
| 0.196 | 0.015 | 0.589 | Mediator release inhibitor | 0.589 0.004 CID_101649831 | CID_101649831 | |
| 0.274 | 0.094 | 0.313 | Caspase 3 stimulant | 0.313 0.073 CID_101649831 | CID_101649831 | |
| 0.268 | 0.089 | 0.57 | Immunostimulant | 0.358 0.062 CID_10446031 0.57 0.02 CID_101649831 | CID_101649831 | |
| 0.221 | 0.043 | 0.221 | Histone acetyltransferase inhibitor | |||
| 0.203 | 0.027 | 0.203 | GABA C receptor rho-2 antagonist | |||
| 0.198 | 0.023 | 0.198 | Ferrochelatase inhibitor | |||
| 0.186 | 0.011 | 0.186 | ABCA1 expression enhancer | 0.091 0.064 CID_10446031 | ||
| 0.254 | 0.08 | 0.254 | Transcription factor STAT3 inhibitor | |||
| 0.195 | 0.021 | 0.501 | Expectorant | 0.091 0.079 CID_10446031 0.501 0.004 CID_101649831 | CID_101649831 | |
| 0.205 | 0.032 | 0.205 | Neurotensin receptor agonist | |||
| 0.201 | 0.027 | 0.233 | Aldehyde dehydrogenase inhibitor | 0.233 0.021 CID_101649831 | CID_101649831 | |
| 0.177 | 0.004 | 0.177 | Acetyl-CoA transferase 1 inhibitor | 0.054 0.013 CID_10446031 0.038 0.033 CID_101649831 | ||
| 0.179 | 0.008 | 0.179 | Ca2+-transporting ATPase inhibitor | 0.137 0.083 CID_10446031 0.174 0.01 CID_101649831 | ||
| 0.207 | 0.037 | 0.229 | Interleukin 6 antagonist | 0.229 0.028 CID_101649831 | CID_101649831 | |
| 0.206 | 0.039 | 0.206 | Phospholipase A2 inhibitor | 0.158 0.067 CID_10446031 0.143 0.083 CID_101649831 | ||
| 0.198 | 0.031 | 0.198 | Cyclooxygenase 2 inhibitor | 0.169 0.042 CID_10446031 | ||
| 0.182 | 0.015 | 0.182 | Papain-like protease (SARS coronavirus) inhibitor | |||
| 0.175 | 0.009 | 0.175 | Phenylalanine 4-hydroxylase inhibitor | 0.075 0.041 CID_10446031 | ||
| 0.171 | 0.005 | 0.206 | Estrogen receptor beta agonist | 0.206 0.004 CID_10446031 0.085 0.014 CID_101649831 | CID_10446031 | |
| 0.183 | 0.017 | 0.183 | Pregnane X receptor agonist | 0.151 0.051 CID_10446031 | ||
| 0.172 | 0.007 | 0.172 | TRPA1 antagonist | |||
| 0.174 | 0.009 | 0.174 | Glutamate decarboxylase inhibitor | 0.084 0.041 CID_10446031 | ||
| 0.213 | 0.049 | 0.213 | Lipocortins synthesis antagonist | 0.171 0.079 CID_101649831 | ||
| 0.238 | 0.077 | 0.238 | Calpain inhibitor | |||
| 0.188 | 0.03 | 0.188 | Toll-Like receptor 2 antagonist | |||
| 0.203 | 0.047 | 0.203 | Antipruritic | |||
| 0.174 | 0.021 | 0.174 | Potassium channel (Ca-activated) activator | |||
| 0.16 | 0.009 | 0.16 | Ornithine decarboxylase inhibitor | 0.095 0.05 CID_10446031 0.12 0.026 CID_101649831 | ||
| 0.165 | 0.015 | 0.165 | NAD(P)H dehydrogenase (quinone) inhibitor | |||
| 0.188 | 0.038 | 0.188 | Interleukin 1 antagonist | |||
| 0.231 | 0.082 | 0.389 | Vasodilator | 0.389 0.025 CID_101649831 | CID_101649831 | |
| 0.159 | 0.011 | 0.159 | Estrogen receptor alpha antagonist | 0.072 0.063 CID_10446031 | ||
| 0.189 | 0.042 | 0.347 | Hexokinase inhibitor | 0.347 0.006 CID_101649831 | CID_101649831 | |
| 0.209 | 0.064 | 0.209 | Insulin sensitizer | 0.149 0.134 CID_10446031 0.185 0.09 CID_101649831 | ||
| 0.18 | 0.036 | 0.18 | CF transmembrane conductance regulator agonist | 0.135 0.107 CID_101649831 | ||
| 0.16 | 0.018 | 0.16 | Histidine decarboxylase inhibitor | |||
| 0.207 | 0.065 | 0.305 | DNA methyltransferase I inhibitor | 0.305 0.024 CID_101649831 | CID_101649831 | |
| 0.154 | 0.012 | 0.277 | CDC25A inhibitor | 0.277 0.004 CID_10446031 0.07 0.057 CID_101649831 | CID_10446031 | |
| 0.197 | 0.059 | 0.197 | Amyloid beta precursor protein antagonist | |||
| 0.162 | 0.024 | 0.246 | Photosensitizer | 0.246 0.006 CID_101649831 | CID_101649831 | |
| 0.154 | 0.016 | 0.167 | Anabolic | 0.167 0.011 CID_10446031 0.1 0.062 CID_101649831 | CID_10446031 | |
| 0.167 | 0.03 | 0.182 | Beta amyloid protein antagonist | 0.182 0.023 CID_101649831 | CID_101649831 | |
| 0.169 | 0.035 | 0.169 | Sphingosine 1-phosphate receptor 5 antagonist | |||
| 0.158 | 0.024 | 0.158 | Adenylate kinase inhibitor | 0.108 0.056 CID_10446031 0.117 0.046 CID_101649831 | ||
| 0.16 | 0.028 | 0.177 | Heat shock protein 70 antagonist | 0.177 0.013 CID_101649831 | CID_101649831 | |
| 0.154 | 0.022 | 0.154 | Androgen antagonist | |||
| 0.148 | 0.018 | 0.288 | NADH dehydrogenase inhibitor | 0.1 0.043 CID_10446031 0.288 0.007 CID_101649831 | CID_101649831 | |
| 0.141 | 0.012 | 0.157 | Glutamate release inhibitor | 0.157 0.008 CID_101649831 | CID_101649831 | |
| 0.132 | 0.003 | 0.132 | Dopamine D5 agonist | 0.037 0.033 CID_10446031 | ||
| 0.134 | 0.006 | 0.134 | 3(or 17)beta-hydroxysteroid dehydrogenase inhibitor | 0.09 0.013 CID_10446031 | ||
| 0.152 | 0.024 | 0.402 | Beta glucuronidase inhibitor | 0.402 0.004 CID_101649831 | CID_101649831 | |
| 0.139 | 0.011 | 0.139 | Leukotriene synthesis inhibitor | |||
| 0.159 | 0.033 | 0.198 | Microtubule formation inhibitor | 0.198 0.02 CID_101649831 | CID_101649831 | |
| 0.125 | 0.002 | 0.185 | Thyroid hormone agonist | 0.185 0.002 CID_10446031 0.037 0.007 CID_101649831 | CID_10446031 | |
| 0.141 | 0.018 | 0.141 | Macrophage migration inhibitory factor inhibitor | |||
| 0.201 | 0.08 | 0.201 | Pyruvate kinase inhibitor | |||
| 0.166 | 0.045 | 0.166 | M18 aspartyl aminopeptidase inhibitor | |||
| 0.147 | 0.027 | 0.196 | UDP-N-acetylglucosamine 1-carboxyvinyltransferase inhibitor | 0.196 0.016 CID_101649831 | CID_101649831 | |
| 0.166 | 0.048 | 0.166 | Bone formation stimulant | |||
| 0.121 | 0.004 | 0.18 | Adenine nucleotide translocase inhibitor | 0.18 0.003 CID_10446031 0.078 0.01 CID_101649831 | CID_10446031 | |
| 0.146 | 0.03 | 0.149 | Carbonic anhydrase III inhibitor | 0.149 0.029 CID_10446031 0.109 0.053 CID_101649831 | CID_10446031 | |
| 0.158 | 0.043 | 0.305 | Alkylator | 0.128 0.061 CID_10446031 0.305 0.012 CID_101649831 | CID_101649831 | |
| 0.12 | 0.004 | 0.12 | Heme oxygenase stimulant | 0.082 0.014 CID_10446031 0.072 0.023 CID_101649831 | ||
| 0.121 | 0.006 | 0.121 | Estrogen receptor alpha agonist | 0.03 0.026 CID_10446031 | ||
| 0.131 | 0.017 | 0.462 | HIV-1 integrase (3'-Processing) inhibitor | 0.462 0.004 CID_10446031 0.073 0.037 CID_101649831 | CID_10446031 | |
| 0.141 | 0.026 | 0.141 | GABA C receptor rho-1 antagonist | |||
| 0.138 | 0.024 | 0.142 | Carbonic anhydrase VI inhibitor | 0.142 0.023 CID_10446031 0.072 0.069 CID_101649831 | CID_10446031 | |
| 0.127 | 0.014 | 0.13 | Bile acid receptor antagonist | 0.13 0.013 CID_10446031 0.093 0.066 CID_101649831 | CID_10446031 | |
| 0.158 | 0.045 | 0.198 | DNA polymerase I inhibitor | 0.198 0.029 CID_101649831 | CID_101649831 | |
| 0.15 | 0.038 | 0.183 | Aminopeptidase B inhibitor | 0.183 0.026 CID_10446031 | CID_10446031 | |
| 0.133 | 0.022 | 0.246 | Phosphofructokinase-1 inhibitor | 0.072 0.046 CID_10446031 0.246 0.008 CID_101649831 | CID_101649831 | |
| 0.127 | 0.015 | 0.41 | HIV-1 integrase (Strand Transfer) inhibitor | 0.41 0.004 CID_10446031 0.072 0.035 CID_101649831 | CID_10446031 | |
| 0.144 | 0.033 | 0.144 | Carbonic anhydrase XV inhibitor | 0.091 0.081 CID_10446031 | ||
| 0.211 | 0.1 | 0.211 | Neuropeptide Y2 antagonist | |||
| 0.139 | 0.029 | 0.181 | Catalase inhibitor | 0.181 0.019 CID_10446031 | CID_10446031 | |
| 0.13 | 0.02 | 0.13 | GABA A receptor agonist | |||
| 0.123 | 0.015 | 0.123 | GABA aminotransferase inhibitor | 0.118 0.017 CID_101649831 | ||
| 0.169 | 0.062 | 0.554 | Diuretic | 0.554 0.005 CID_10446031 0.269 0.028 CID_101649831 | CID_10446031 | |
| 0.129 | 0.022 | 0.154 | Interleukin 12 antagonist | 0.154 0.011 CID_101649831 | CID_101649831 | |
| 0.137 | 0.031 | 0.137 | Urease inhibitor | |||
| 0.136 | 0.03 | 0.136 | Electron transport complex I inhibitor | |||
| 0.161 | 0.055 | 0.395 | Cell wall synthesis inhibitor | 0.299 0.01 CID_10446031 0.395 0.006 CID_101649831 | CID_101649831 | |
| 0.129 | 0.023 | 0.129 | Lanosterol 14 alpha demethylase inhibitor | |||
| 0.11 | 0.004 | 0.11 | Alpha 1L adrenoreceptor antagonist | 0.053 0.034 CID_10446031 | ||
| 0.175 | 0.07 | 0.175 | 3C-like protease (Human coronavirus) inhibitor | |||
| 0.113 | 0.011 | 0.113 | CC chemokine 5 receptor agonist | 0.104 0.017 CID_10446031 | ||
| 0.196 | 0.094 | 0.196 | ErbB-1 antagonist | |||
| 0.274 | 0.173 | 0.57 | Alpha-glucosidase inhibitor | 0.57 0.061 CID_101649831 | CID_101649831 | |
| 0.187 | 0.088 | 0.187 | 5 Hydroxytryptamine 3E antagonist | |||
| 0.104 | 0.005 | 0.104 | Retinoid X alpha receptor agonist | |||
| 0.14 | 0.041 | 0.14 | Interleukin 8 antagonist | |||
| 0.118 | 0.02 | 0.118 | 3C-Like protease (SARS coronavirus) inhibitor | |||
| 0.117 | 0.022 | 0.144 | ATPase (Vacuolar H+) inhibitor | 0.144 0.009 CID_101649831 | CID_101649831 | |
| 0.197 | 0.104 | 0.197 | Aryl hydrocarbon receptor agonist | |||
| 0.113 | 0.021 | 0.113 | Granulocyte macrophage colony stimulating factor agonist | |||
| 0.175 | 0.084 | 0.195 | P-glycoprotein inhibitor | 0.195 0.067 CID_101649831 | CID_101649831 | |
| 0.11 | 0.019 | 0.11 | D-Ala-D-Ala ligase inhibitor | |||
| 0.157 | 0.067 | 0.342 | Insulin secretagoues | 0.342 0.009 CID_101649831 | CID_101649831 | |
| 0.145 | 0.055 | 0.167 | Interleukin 4 antagonist | 0.167 0.036 CID_101649831 | CID_101649831 | |
| 0.112 | 0.022 | 0.112 | Aminopeptidase I inhibitor | |||
| 0.115 | 0.026 | 0.115 | Glutathione S-transferase inhibitor | |||
| 0.096 | 0.009 | 0.096 | Sphingosine kinase 2 inhibitor | |||
| 0.112 | 0.025 | 0.112 | Glutamate dehydrogenase inhibitor | 0.069 0.058 CID_10446031 0.077 0.047 CID_101649831 | ||
| 0.094 | 0.007 | 0.094 | Calcium channel P-type blocker | |||
| 0.123 | 0.036 | 0.196 | Uric acid excretion stimulant | 0.196 0.014 CID_101649831 | CID_101649831 | |
| 0.101 | 0.015 | 0.101 | CDC25B inhibitor | |||
| 0.145 | 0.06 | 0.145 | Nav1.6 sodium channel blocker | |||
| 0.147 | 0.062 | 0.203 | Alkaline phosphatase inhibitor | 0.203 0.032 CID_10446031 0.166 0.05 CID_101649831 | CID_10446031 | |
| 0.099 | 0.015 | 0.099 | Androgen agonist | 0.087 0.02 CID_10446031 | ||
| 0.101 | 0.017 | 0.107 | 3-Oxoacyl-[acyl-carrier-protein] synthase inhibitor | 0.107 0.015 CID_101649831 | CID_101649831 | |
| 0.089 | 0.006 | 0.089 | Retinoid X receptor agonist | |||
| 0.134 | 0.051 | 0.134 | Sphingosine 1-phosphate receptor 4 antagonist | |||
| 0.087 | 0.004 | 0.087 | Geranyltranstransferase inhibitor | |||
| 0.107 | 0.026 | 0.13 | Na+ K+ transporting ATPase inhibitor | 0.113 0.021 CID_10446031 0.13 0.011 CID_101649831 | CID_101649831 | |
| 0.088 | 0.008 | 0.088 | Dihydroorotate oxidase inhibitor | 0.051 0.047 CID_10446031 | ||
| 0.129 | 0.05 | 0.295 | Topoisomerase I inhibitor | 0.295 0.011 CID_101649831 | CID_101649831 | |
| 0.134 | 0.056 | 0.134 | Proteasome inhibitor | |||
| 0.121 | 0.044 | 0.121 | Bronchodilator | |||
| 0.126 | 0.05 | 0.126 | Transcription factor STAT6 inhibitor | |||
| 0.084 | 0.007 | 0.084 | Ryanodine receptor antagonist | |||
| 0.095 | 0.018 | 0.095 | Purinergic P2X1 antagonist | 0.058 0.047 CID_10446031 | ||
| 0.095 | 0.019 | 0.095 | Bombesin 1 receptor agonist | |||
| 0.078 | 0.002 | 0.078 | Thyroid hormone beta agonist | |||
| 0.173 | 0.097 | 0.173 | I kappa B kinase epsilon inhibitor | |||
| 0.095 | 0.019 | 0.095 | Peroxisome proliferator-activated receptor gamma antagonist | |||
| 0.08 | 0.004 | 0.08 | Alpha 1L adrenoreceptor agonist | 0.05 0.016 CID_10446031 | ||
| 0.241 | 0.165 | 0.486 | Antiobesity | 0.486 0.041 CID_10446031 0.33 0.098 CID_101649831 | CID_10446031 | |
| 0.133 | 0.057 | 0.133 | Adenylate cyclase inhibitor | |||
| 0.094 | 0.019 | 0.094 | MAP kinase kinase 7 inhibitor | |||
| 0.081 | 0.006 | 0.081 | Pregnane X receptor antagonist | |||
| 0.099 | 0.024 | 0.099 | Potassium channel large-conductance Ca-activated activator | |||
| 0.081 | 0.007 | 0.081 | Cholesterol esterase inhibitor | |||
| 0.121 | 0.047 | 0.121 | Nav1.1 sodium channel blocker | |||
| 0.094 | 0.021 | 0.094 | Argininosuccinate synthase inhibitor | 0.056 0.04 CID_101649831 | ||
| 0.137 | 0.065 | 0.137 | Toll-Like receptor antagonist | |||
| 0.16 | 0.088 | 0.16 | Tumour necrosis factor antagonist | |||
| 0.092 | 0.021 | 0.092 | Biliverdin reductase inhibitor | 0.054 0.048 CID_101649831 | ||
| 0.102 | 0.031 | 0.155 | Glycine receptor antagonist | 0.155 0.006 CID_10446031 0.142 0.009 CID_101649831 | CID_10446031 | |
| 0.093 | 0.023 | 0.093 | Carbamoyl phosphate synthetase inhibitor | 0.056 0.048 CID_10446031 | ||
| 0.103 | 0.035 | 0.103 | Adrenaline agonist | |||
| 0.076 | 0.008 | 0.076 | Estrogen-related receptor alpha antagonist | |||
| 0.11 | 0.043 | 0.114 | Alcohol dehydrogenase inhibitor | 0.114 0.039 CID_101649831 | CID_101649831 | |
| 0.096 | 0.029 | 0.096 | Prostaglandin-E synthase inhibitor | |||
| 0.08 | 0.014 | 0.08 | Aconitate hydratase inhibitor | |||
| 0.073 | 0.006 | 0.073 | Alpha 1d adrenoreceptor agonist | |||
| 0.112 | 0.046 | 0.112 | Folate antagonist | 0.112 0.047 CID_101649831 | ||
| 0.086 | 0.02 | 0.086 | Acyl-CoA dehydrogenase inhibitor | |||
| 0.094 | 0.029 | 0.155 | HIV-1 integrase inhibitor | 0.155 0.008 CID_10446031 | CID_10446031 | |
| 0.095 | 0.03 | 0.095 | Lipase inhibitor | |||
| 0.09 | 0.026 | 0.09 | Leukotriene antagonist | 0.079 0.033 CID_10446031 0.063 0.047 CID_101649831 | ||
| 0.109 | 0.046 | 0.109 | Interleukin 1 beta converting enzyme inhibitor | |||
| 0.075 | 0.012 | 0.075 | Squalene epoxidase inhibitor | |||
| 0.067 | 0.005 | 0.067 | 3-Hydroxyanthranilate 3,4-dioxygenase inhibitor | 0.047 0.018 CID_10446031 | ||
| 0.119 | 0.057 | 0.119 | 5 Hydroxytryptamine 3A agonist | |||
| 0.069 | 0.006 | 0.069 | Purinergic P2X3 antagonist | |||
| 0.075 | 0.013 | 0.075 | Acetyl-CoA transferase 2 inhibitor | |||
| 0.085 | 0.023 | 0.085 | Maillard reaction inhibitor | |||
| 0.083 | 0.021 | 0.083 | Beta 3 adrenoreceptor antagonist | |||
| 0.081 | 0.02 | 0.085 | Mannitol-1-phosphate 5-dehydrogenase inhibitor | 0.085 0.018 CID_101649831 | CID_101649831 | |
| 0.082 | 0.022 | 0.082 | Glutamate (mGluR6) antagonist | |||
| 0.074 | 0.014 | 0.074 | Estradiol 17 beta-dehydrogenase inhibitor | |||
| 0.069 | 0.009 | 0.069 | Liver X receptor alpha agonist | |||
| 0.073 | 0.014 | 0.073 | Potassium channel Kv1.3 blocker | |||
| 0.068 | 0.009 | 0.068 | Estradiol 17 beta-dehydrogenase 2 inhibitor | |||
| 0.063 | 0.005 | 0.063 | Retinoid X receptor antagonist | |||
| 0.07 | 0.012 | 0.099 | Glucose-6-phosphate isomerase inhibitor | 0.05 0.03 CID_10446031 0.099 0.005 CID_101649831 | CID_101649831 | |
| 0.077 | 0.019 | 0.111 | Sphingosine kinase inhibitor | 0.111 0.005 CID_10446031 | CID_10446031 | |
| 0.072 | 0.014 | 0.341 | Leukocyte elastase inhibitor | 0.341 0.003 CID_10446031 | CID_10446031 | |
| 0.096 | 0.04 | 0.315 | Carbonic anhydrase XIII inhibitor | 0.315 0.005 CID_10446031 0.152 0.021 CID_101649831 | CID_10446031 | |
| 0.076 | 0.02 | 0.076 | Sphingosine 1-phosphate receptor 3 antagonist | |||
| 0.082 | 0.025 | 0.082 | Glutamate (mGluR7) antagonist | |||
| 0.066 | 0.01 | 0.066 | Dopamine beta hydroxylase inhibitor | |||
| 0.182 | 0.126 | 0.423 | Peptidyltransferase inhibitor | 0.423 0.005 CID_101649831 | CID_101649831 | |
| 0.103 | 0.047 | 0.131 | Phosphodiesterase 6D inhibitor | 0.131 0.017 CID_101649831 | CID_101649831 | |
| 0.071 | 0.015 | 0.113 | Glucose-6-phosphate translocase inhibitor | 0.113 0.005 CID_101649831 | CID_101649831 | |
| 0.068 | 0.014 | 0.068 | CXC chemokine 1 receptor antagonist | 0.051 0.035 CID_10446031 | ||
| 0.154 | 0.101 | 0.471 | Platelet adhesion inhibitor | 0.443 0.008 CID_10446031 0.471 0.006 CID_101649831 | CID_101649831 | |
| 0.057 | 0.004 | 0.057 | Glutamate (mGluR3) agonist | 0.03 0.028 CID_101649831 | ||
| 0.058 | 0.005 | 0.058 | ATP citrate lysase inhibitor | |||
| 0.075 | 0.022 | 0.075 | Cyclin D1 inhibitor | |||
| 0.094 | 0.041 | 0.094 | mTOR complex 2 inhibitor | |||
| 0.065 | 0.013 | 0.065 | Oxytocin agonist | |||
| 0.078 | 0.026 | 0.078 | NMDA 2C receptor antagonist | 0.074 0.029 CID_10446031 | ||
| 0.057 | 0.005 | 0.057 | HMG CoA reductase inhibitor | 0.04 0.015 CID_101649831 | ||
| 0.099 | 0.047 | 0.271 | Antineoplastic antibiotic | 0.1 0.046 CID_10446031 0.271 0.012 CID_101649831 | CID_101649831 | |
| 0.072 | 0.02 | 0.072 | Glycine transporter 2 inhibitor | |||
| 0.062 | 0.011 | 0.062 | Nicotinic acid receptor agonist | |||
| 0.074 | 0.023 | 0.074 | Transcription factor RelA inhibitor | |||
| 0.056 | 0.006 | 0.056 | Liver X receptor beta antagonist | |||
| 0.073 | 0.024 | 0.073 | GABA receptor antagonist | 0.054 0.038 CID_10446031 | ||
| 0.052 | 0.003 | 0.052 | Estrogen-related receptor gamma antagonist | 0.032 0.013 CID_10446031 | ||
| 0.078 | 0.029 | 0.078 | Beta adrenoreceptor antagonist | |||
| 0.054 | 0.005 | 0.059 | Cholesterol ester transfer protein antagonist | 0.059 0.005 CID_10446031 | CID_10446031 | |
| 0.053 | 0.005 | 0.053 | Retinoid X alpha receptor antagonist | |||
| 0.068 | 0.021 | 0.068 | 5 Hydroxytryptamine 7 agonist | |||
| 0.061 | 0.014 | 0.061 | Urate transporter 1 inhibitor | |||
| 0.07 | 0.024 | 0.07 | Alpha tubulin antagonist | |||
| 0.123 | 0.077 | 0.123 | Tubulin antagonist | |||
| 0.105 | 0.06 | 0.147 | Gastric antisecretory | 0.147 0.028 CID_10446031 | CID_10446031 | |
| 0.107 | 0.062 | 0.285 | AMP-activated protein kinase stimulant | 0.285 0.005 CID_101649831 | CID_101649831 | |
| 0.061 | 0.015 | 0.061 | 5-Alpha-reductase inhibitor | |||
| 0.068 | 0.023 | 0.068 | Beta 2 adrenoreceptor agonist | |||
| 0.075 | 0.03 | 0.075 | Aromatase inhibitor | 0.052 0.047 CID_10446031 | ||
| 0.062 | 0.017 | 0.062 | Adenylate cyclase 1 inhibitor | |||
| 0.074 | 0.03 | 0.074 | MDM2 inhibitor | |||
| 0.083 | 0.039 | 0.083 | Sphingosine 1-phosphate receptor antagonist | |||
| 0.071 | 0.027 | 0.071 | Corticotropin releasing factor 2 receptor antagonist | |||
| 0.122 | 0.079 | 0.122 | Antibacterial (Helicobacter pylori) | 0.115 0.089 CID_10446031 | ||
| 0.069 | 0.026 | 0.069 | GABA A receptor antagonist | |||
| 0.089 | 0.047 | 0.236 | Topoisomerase II alpha inhibitor | 0.236 0.011 CID_101649831 | CID_101649831 | |
| 0.133 | 0.091 | 0.442 | Hemostatic | 0.425 0.006 CID_10446031 0.442 0.005 CID_101649831 | CID_101649831 | |
| 0.078 | 0.037 | 0.087 | Phospholipase D inhibitor | 0.087 0.026 CID_10446031 | CID_10446031 | |
| 0.068 | 0.027 | 0.068 | Botulinum neurotoxin type A inhibitor | |||
| 0.1 | 0.059 | 0.1 | Nitric-oxide synthase inhibitor | |||
| 0.085 | 0.044 | 0.093 | Interferon agonist | 0.081 0.05 CID_10446031 0.093 0.036 CID_101649831 | CID_101649831 | |
| 0.048 | 0.007 | 0.123 | Sodium/glucose cotransporter 2 inhibitor | 0.123 0.002 CID_101649831 | CID_101649831 | |
| 0.187 | 0.146 | 0.187 | 5 Hydroxytryptamine 1E antagonist | |||
| 0.045 | 0.004 | 0.045 | Retinoid X gamma receptor antagonist | 0.029 0.014 CID_10446031 0.028 0.016 CID_101649831 | ||
| 0.072 | 0.032 | 0.078 | Interferon inducer | 0.071 0.034 CID_10446031 0.078 0.026 CID_101649831 | CID_101649831 | |
| 0.045 | 0.004 | 0.045 | Retinoic acid alpha receptor antagonist | |||
| 0.066 | 0.026 | 0.066 | NMDA 2A receptor antagonist | |||
| 0.057 | 0.017 | 0.057 | Purinergic P2X4 antagonist | |||
| 0.082 | 0.042 | 0.236 | Cathepsin G inhibitor | 0.236 0.013 CID_10446031 | CID_10446031 | |
| 0.172 | 0.133 | 0.465 | Tumour necrosis factor alpha release inhibitor | 0.465 0.018 CID_101649831 | CID_101649831 | |
| 0.092 | 0.053 | 0.092 | Calcium antagonist | |||
| 0.043 | 0.004 | 0.043 | Retinoic acid receptor antagonist | 0.019 0.013 CID_101649831 | ||
| 0.08 | 0.041 | 0.08 | Vanilloid 4 agonist | |||
| 0.088 | 0.05 | 0.096 | Inducible nitric-oxide synthase inhibitor | 0.096 0.041 CID_10446031 | CID_10446031 | |
| 0.099 | 0.061 | 0.099 | Glutamate (mGluR7) agonist | |||
| 0.061 | 0.023 | 0.061 | Beta 2 adrenoreceptor antagonist | |||
| 0.041 | 0.004 | 0.069 | Vanilloid 2 agonist | 0.041 0.004 CID_10446031 0.069 0.002 CID_101649831 | CID_101649831 | |
| 0.044 | 0.008 | 0.044 | Estrogen-related receptor beta antagonist | |||
| 0.044 | 0.008 | 0.044 | Estradiol 17 beta-dehydrogenase 1 inhibitor | |||
| 0.046 | 0.01 | 0.046 | Catechol O-methyltransferase inhibitor | 0.03 0.028 CID_10446031 | ||
| 0.069 | 0.033 | 0.069 | Alpha 2 adrenoreceptor agonist | |||
| 0.052 | 0.017 | 0.062 | Dihydrofolate reductase inhibitor | 0.062 0.009 CID_10446031 | CID_10446031 | |
| 0.11 | 0.075 | 0.11 | Caspase 3 inhibitor | |||
| 0.041 | 0.007 | 0.132 | Sodium/glucose cotransporter inhibitor | 0.132 0.002 CID_101649831 | CID_101649831 | |
| 0.091 | 0.056 | 0.091 | Opioid antagonist | |||
| 0.097 | 0.062 | 0.097 | Electrolyte absorption antagonist | |||
| 0.049 | 0.015 | 0.049 | Kainate receptor agonist | |||
| 0.047 | 0.014 | 0.047 | Glutamate (mGluR8) agonist | |||
| 0.066 | 0.033 | 0.066 | Enoyl-[acyl-carrier-protein] reductase inhibitor | |||
| 0.061 | 0.028 | 0.061 | Leukotriene C antagonist | |||
| 0.038 | 0.005 | 0.038 | Nicotinic acid receptor 2 antagonist | |||
| 0.07 | 0.037 | 0.07 | Aryl hydrocarbon receptor antagonist | |||
| 0.093 | 0.06 | 0.125 | Protein kinase C zeta inhibitor | 0.125 0.029 CID_10446031 | CID_10446031 | |
| 0.06 | 0.027 | 0.12 | Alpha-mannosidase inhibitor | 0.075 0.014 CID_10446031 0.12 0.005 CID_101649831 | CID_101649831 | |
| 0.063 | 0.03 | 0.123 | Aldose reductase inhibitor | 0.078 0.024 CID_10446031 0.123 0.014 CID_101649831 | CID_101649831 | |
| 0.045 | 0.013 | 0.045 | Estradiol 17 beta-dehydrogenase 3 inhibitor | |||
| 0.059 | 0.027 | 0.059 | Immunoglobulin Fc receptor antagonist | |||
| 0.121 | 0.089 | 0.121 | Histone deacetylase SIRT1 inhibitor | |||
| 0.048 | 0.016 | 0.051 | Farnesoid X receptor agonist | 0.051 0.014 CID_10446031 | CID_10446031 | |
| 0.036 | 0.005 | 0.036 | Calcium-sensing receptor antagonist | |||
| 0.056 | 0.025 | 0.056 | Topoisomerase II beta inhibitor | 0.053 0.029 CID_101649831 | ||
| 0.063 | 0.033 | 0.063 | Beta 1 adrenoreceptor antagonist | |||
| 0.063 | 0.032 | 0.063 | Fatty acid synthase inhibitor | |||
| 0.095 | 0.064 | 0.202 | Xanthine oxidase inhibitor | 0.202 0.019 CID_101649831 | CID_101649831 | |
| 0.044 | 0.014 | 0.044 | Vanilloid 3 antagonist | |||
| 0.035 | 0.005 | 0.035 | ICAM 1 antagonist | |||
| 0.033 | 0.004 | 0.033 | Estrogen-related receptor gamma agonist | |||
| 0.148 | 0.118 | 0.183 | Psychostimulant | 0.183 0.091 CID_101649831 | CID_101649831 | |
| 0.105 | 0.076 | 0.134 | Acetylcholine release stimulant | 0.134 0.03 CID_10446031 0.101 0.085 CID_101649831 | CID_10446031 | |
| 0.045 | 0.016 | 0.045 | Fumarate hydratase inhibitor | 0.03 0.029 CID_101649831 | ||
| 0.065 | 0.036 | 0.065 | Phosphodiesterase 1C inhibitor | |||
| 0.05 | 0.021 | 0.058 | Guanylate cyclase inhibitor | 0.05 0.021 CID_10446031 0.058 0.013 CID_101649831 | CID_101649831 | |
| 0.041 | 0.012 | 0.041 | Leukotriene D4 antagonist | |||
| 0.032 | 0.004 | 0.032 | Retinoid X beta receptor antagonist | |||
| 0.068 | 0.039 | 0.068 | Protease 3C (Human rhinovirus) inhibitor | 0.065 0.043 CID_10446031 | ||
| 0.072 | 0.044 | 0.072 | Protein kinase C beta inhibitor | |||
| 0.058 | 0.03 | 0.058 | Thromboxane synthase inhibitor | |||
| 0.032 | 0.004 | 0.032 | Nicotinic acid receptor 1 antagonist | |||
| 0.046 | 0.018 | 0.046 | TRPM8 blocker | |||
| 0.113 | 0.085 | 0.113 | Cathepsin H inhibitor | |||
| 0.038 | 0.01 | 0.038 | Liver X receptor alpha antagonist | |||
| 0.072 | 0.045 | 0.072 | Opioid mu receptor antagonist | |||
| 0.071 | 0.045 | 0.071 | Alpha adrenoreceptor agonist | |||
| 0.07 | 0.043 | 0.07 | Exportin-1 inhibitor | |||
| 0.101 | 0.075 | 0.101 | Protein kinase C gamma inhibitor | |||
| 0.046 | 0.02 | 0.046 | Sphingosine kinase 1 inhibitor | |||
| 0.06 | 0.034 | 0.06 | Ribonucleoside-diphosphate reductase inhibitor | |||
| 0.05 | 0.025 | 0.05 | NMDA receptor subunit 3B antagonist | |||
| 0.061 | 0.036 | 0.061 | Ribonucleotide reductase inhibitor | |||
| 0.031 | 0.007 | 0.031 | Imidazoline I1 receptor antagonist | |||
| 0.04 | 0.016 | 0.04 | Free fatty acid receptor 1 antagonist | |||
| 0.032 | 0.009 | 0.032 | Hedgehog signaling activator | |||
| 0.071 | 0.048 | 0.071 | Peroxisome proliferator-activated receptor gamma agonist | |||
| 0.072 | 0.049 | 0.072 | Calcium channel L-type blocker | |||
| 0.039 | 0.016 | 0.039 | Liver X receptor beta agonist | |||
| 0.069 | 0.047 | 0.069 | Toll-Like receptor 7 antagonist | |||
| 0.052 | 0.031 | 0.052 | Bombesin 2 receptor antagonist | |||
| 0.074 | 0.054 | 0.074 | CYP2A6 inhibitor | |||
| 0.037 | 0.016 | 0.037 | Liver X receptor antagonist | |||
| 0.03 | 0.01 | 0.045 | Glutamate (mGluR1) agonist | 0.045 0.005 CID_10446031 | CID_10446031 | |
| 0.055 | 0.035 | 0.068 | Leukotriene B4 antagonist | 0.068 0.021 CID_10446031 0.066 0.023 CID_101649831 | CID_10446031 | |
| 0.051 | 0.031 | 0.051 | Peroxisome proliferator-activated receptor alpha agonist | |||
| 0.127 | 0.107 | 0.127 | Neuropeptide Y1 antagonist | |||
| 0.118 | 0.098 | 0.118 | Neurotrophic factor | |||
| 0.055 | 0.036 | 0.055 | Thromboxane antagonist | |||
| 0.052 | 0.034 | 0.052 | Thromboxane A2 antagonist | |||
| 0.053 | 0.034 | 0.053 | Dihydroorotate dehydrogenase inhibitor | |||
| 0.026 | 0.007 | 0.026 | Neuraminidase (Influenza B) inhibitor | |||
| 0.062 | 0.045 | 0.062 | Opioid delta receptor antagonist | |||
| 0.042 | 0.024 | 0.042 | AMPA 4 receptor antagonist | |||
| 0.09 | 0.073 | 0.09 | Sphingomyelinase inhibitor | |||
| 0.039 | 0.022 | 0.039 | Glutamate (mGluR3) antagonist | |||
| 0.022 | 0.006 | 0.032 | Telomerase stimulant | 0.032 0.003 CID_101649831 | CID_101649831 | |
| 0.045 | 0.029 | 0.045 | AICAR transformylase inhibitor | 0.04 0.037 CID_10446031 | ||
| 0.03 | 0.014 | 0.03 | CXC chemokine 2 receptor antagonist | |||
| 0.024 | 0.008 | 0.024 | Thymidine kinase (Herpes simplex virus 2) inhibitor | |||
| 0.061 | 0.046 | 0.061 | Histone deacetylase SIRT3 inhibitor | |||
| 0.02 | 0.004 | 0.02 | Retinoic acid beta receptor antagonist | |||
| 0.033 | 0.018 | 0.033 | Cyclophilin A inhibitor | |||
| 0.026 | 0.011 | 0.047 | Dopamine D1 agonist | 0.047 0.005 CID_10446031 0.031 0.008 CID_101649831 | CID_10446031 | |
| 0.058 | 0.043 | 0.058 | Carbonic anhydrase stimulant | |||
| 0.08 | 0.066 | 0.08 | Myeloperoxidase inhibitor | |||
| 0.04 | 0.025 | 0.04 | NMDA receptor subunit 3A antagonist | |||
| 0.045 | 0.031 | 0.117 | Mannosidase inhibitor | 0.062 0.015 CID_10446031 0.117 0.005 CID_101649831 | CID_101649831 | |
| 0.031 | 0.017 | 0.031 | Uridine phosphorylase inhibitor | 0.03 0.018 CID_101649831 | ||
| 0.094 | 0.08 | 0.183 | Toll-Like receptor 4 antagonist | 0.183 0.009 CID_101649831 | CID_101649831 | |
| 0.03 | 0.017 | 0.03 | Purinergic P2Y15 antagonist | |||
| 0.026 | 0.013 | 0.026 | Peroxisome proliferator-activated receptor alpha antagonist | |||
| 0.034 | 0.021 | 0.034 | Melatonin receptor 1A agonist | |||
| 0.051 | 0.038 | 0.051 | Vanilloid 2 antagonist | |||
| 0.021 | 0.008 | 0.064 | Ileal bile acid transport inhibitor | 0.064 0.003 CID_101649831 | CID_101649831 | |
| 0.021 | 0.009 | 0.038 | Antibiotic Anthracycline-like | 0.038 0.003 CID_101649831 | CID_101649831 | |
| 0.025 | 0.013 | 0.025 | Prostaglandin F2 alpha agonist | |||
| 0.039 | 0.027 | 0.039 | Leukotriene C4 antagonist | |||
| 0.016 | 0.005 | 0.016 | Retinoic acid receptor gamma antagonist | |||
| 0.055 | 0.043 | 0.055 | Beta tubulin antagonist | |||
| 0.051 | 0.039 | 0.051 | Ornithine carbamoyltransferase inhibitor | |||
| 0.045 | 0.033 | 0.045 | Beta adrenoreceptor agonist | |||
| 0.061 | 0.05 | 0.136 | Neuraminidase (influenza) inhibitor | 0.136 0.009 CID_10446031 0.13 0.01 CID_101649831 | CID_10446031 | |
| 0.024 | 0.013 | 0.024 | Isoleucine-tRNA ligase inhibitor | |||
| 0.024 | 0.013 | 0.049 | Glutamate (mGluR1a) agonist | 0.049 0.005 CID_10446031 | CID_10446031 | |
| 0.039 | 0.029 | 0.039 | CF transmembrane conductance regulator antagonist | |||
| 0.053 | 0.042 | 0.124 | Carbonic anhydrase VB inhibitor | 0.124 0.012 CID_10446031 | CID_10446031 | |
| 0.028 | 0.018 | 0.028 | Lysine carboxypeptidase inhibitor | |||
| 0.098 | 0.088 | 0.309 | Topoisomerase II inhibitor | 0.309 0.017 CID_101649831 | CID_101649831 | |
| 0.03 | 0.02 | 0.03 | Complement C5a chemotactic receptor antagonist | |||
| 0.033 | 0.024 | 0.033 | Peroxisome proliferator-activated receptor delta agonist | |||
| 0.014 | 0.005 | 0.014 | Imidazoline I2 receptor antagonist | |||
| 0.086 | 0.077 | 0.086 | Toll-Like receptor 3 antagonist | |||
| 0.044 | 0.035 | 0.044 | Opioid mu receptor agonist | |||
| 0.02 | 0.011 | 0.02 | Alpha 2b adrenoreceptor agonist | |||
| 0.023 | 0.014 | 0.023 | Protease (Human cytomegalovirus) inhibitor | |||
| 0.18 | 0.172 | 0.18 | Prostaglandin dehydrogenase inhibitor | |||
| 0.043 | 0.034 | 0.043 | Fructose-1,6-bisphosphatase inhibitor | |||
| 0.022 | 0.014 | 0.022 | Vitamin D receptor antagonist | 0.022 0.016 CID_101649831 | ||
| 0.019 | 0.01 | 0.019 | Alpha 2a adrenoreceptor agonist | |||
| 0.026 | 0.018 | 0.026 | Prostaglandin H2 antagonist | |||
| 0.015 | 0.007 | 0.015 | Integrin alphaLbeta2 antagonist | |||
| 0.081 | 0.074 | 0.081 | Phosphodiesterase I inhibitor | |||
| 0.033 | 0.027 | 0.037 | Phosphoglycerate kinase inhibitor | 0.037 0.022 CID_10446031 | CID_10446031 | |
| 0.057 | 0.051 | 0.079 | NMDA receptor agonist | 0.079 0.029 CID_10446031 | CID_10446031 | |
| 0.076 | 0.07 | 0.084 | NMDA receptor antagonist | 0.084 0.06 CID_10446031 | CID_10446031 | |
| 0.022 | 0.017 | 0.022 | CYP24 inhibitor | |||
| 0.014 | 0.009 | 0.014 | Integrin beta6 antagonist | |||
| 0.04 | 0.035 | 0.04 | Histamine H2 receptor agonist | |||
| 0.098 | 0.093 | 0.098 | MAO inhibitor | |||
| 0.031 | 0.026 | 0.031 | Calcitonin receptor agonist | |||
| 0.047 | 0.042 | 0.047 | CD45 antagonist | |||
| 0.019 | 0.014 | 0.019 | 5-Alpha-reductase 2 inhibitor | |||
| 0.029 | 0.024 | 0.029 | Endothelial nitric-oxide synthase inhibitor | |||
| 0.034 | 0.03 | 0.034 | Bombesin 1 receptor antagonist | |||
| 0.028 | 0.025 | 0.028 | Glucocorticoid antagonist | |||
| 0.038 | 0.034 | 0.041 | Thymidine kinase inhibitor | 0.041 0.029 CID_10446031 | CID_10446031 | |
| 0.027 | 0.024 | 0.027 | Glucagon receptor antagonist | |||
| 0.036 | 0.033 | 0.036 | Dihydropteroate synthase inhibitor | |||
| 0.051 | 0.048 | 0.051 | Epithelial sodium channel blocker | |||
| 0.014 | 0.012 | 0.014 | NMDA receptor phencyclidine site antagonist | |||
| 0.012 | 0.009 | 0.012 | Glutamate (mGluR6) agonist | |||
| 0.017 | 0.015 | 0.017 | Methylmalonyl-CoA mutase inhibitor | |||
| 0.036 | 0.034 | 0.036 | Membrane dipeptidase inhibitor | |||
| 0.015 | 0.014 | 0.015 | Vitamin D receptor agonist | |||
| 0.025 | 0.024 | 0.025 | LFA antagonist | |||
| 0.01 | 0.009 | 0.01 | Thromboxane agonist | |||
| 0.013 | 0.012 | 0.013 | Integrin alphaVbeta6 antagonist | |||
| 0.018 | 0.017 | 0.018 | Caspase 8 inhibitor | |||
| 0.046 | 0.047 | 0.063 | Factor III inhibitor | 0.063 0.015 CID_101649831 | CID_101649831 | |
| 0.046 | 0.049 | 0.162 | Elastase inhibitor | 0.162 0.004 CID_10446031 | CID_10446031 | |
| 0.026 | 0.029 | 0.045 | 1,3-Beta-glucan synthase inhibitor | 0.045 0.003 CID_10446031 0.033 0.008 CID_101649831 | CID_10446031 | |
| 0.059 | 0.062 | 0.155 | Carbonic anhydrase VA inhibitor | 0.155 0.01 CID_10446031 | CID_10446031 | |
| 0.079 | 0.084 | 0.136 | Thioredoxin inhibitor | 0.136 0.022 CID_101649831 | CID_101649831 | |
| 0.052 | 0.058 | 0.072 | Lipocortins synthesis agonist | 0.072 0.019 CID_101649831 | CID_101649831 | |
| 0.059 | 0.064 | 0.107 | NMDA 2 receptor antagonist | 0.107 0.029 CID_10446031 | CID_10446031 | |
| 0.047 | 0.054 | 0.138 | Heparanase inhibitor | 0.073 0.01 CID_10446031 0.138 0.003 CID_101649831 | CID_101649831 | |
| 0.05 | 0.058 | 0.107 | Neuraminidase inhibitor | 0.09 0.019 CID_10446031 0.107 0.013 CID_101649831 | CID_101649831 | |
| 0.068 | 0.076 | 0.107 | Chymotrypsin inhibitor | 0.107 0.032 CID_10446031 | CID_10446031 | |
| 0.038 | 0.048 | 0.067 | Neuraminidase (Influenza A) inhibitor | 0.067 0.009 CID_101649831 | CID_101649831 | |
| 0.053 | 0.063 | 0.212 | Carbonic anhydrase V inhibitor | 0.212 0.006 CID_10446031 | CID_10446031 | |
| 0.076 | 0.087 | 0.133 | Breast cancer-resistant protein inhibitor | 0.133 0.031 CID_10446031 | CID_10446031 | |
| 0.025 | 0.036 | 0.064 | Arginase inhibitor | 0.064 0.009 CID_101649831 | CID_101649831 | |
| 0.038 | 0.053 | 0.083 | Carbonic anhydrase XIV inhibitor | 0.083 0.016 CID_101649831 | CID_101649831 | |
| 0.006 | 0.026 | 0.01 | Purinergic P2Y2 agonist | 0.01 0.009 CID_101649831 | CID_101649831 | |
| 0.041 | 0.062 | 0.05 | Cytokine production stimulant | 0.05 0.029 CID_101649831 | CID_101649831 | |
| 0.036 | 0.061 | 0.069 | Carbonic anhydrase II inhibitor | 0.069 0.03 CID_10446031 | CID_10446031 | |
| 0.136 | 0.161 | 0.344 | Platelet antagonist | 0.192 0.107 CID_10446031 0.344 0.04 CID_101649831 | CID_101649831 | |
| 0.024 | 0.051 | 0.077 | Purinergic P2Y2 antagonist | 0.077 0.005 CID_10446031 | CID_10446031 | |
| 0.039 | 0.072 | 0.161 | Carbonic anhydrase inhibitor | 0.161 0.014 CID_10446031 | CID_10446031 | |
| 0.098 | 0.137 | 0.185 | DNA repair enzyme inhibitor | 0.185 0.012 CID_101649831 | CID_101649831 | |
| 0.01 | 0.05 | 0.174 | Estrone sulfatase inhibitor | 0.174 0.003 CID_10446031 | CID_10446031 | |
| 0.069 | 0.112 | 0.163 | DNA directed RNA polymerase inhibitor | 0.163 0.02 CID_101649831 | CID_101649831 | |
| 0.044 | 0.089 | 0.056 | Transcription factor AP-1 inhibitor | 0.056 0.053 CID_101649831 | CID_101649831 | |
| 0.041 | 0.092 | 0.076 | Nitric oxide donor | 0.076 0.026 CID_101649831 | CID_101649831 | |
| 0.002 | 0.06 | 0.016 | Antibiotic Macrolide-like | 0.016 0.009 CID_101649831 | CID_101649831 | |
| 0.024 | 0.084 | 0.06 | Carbonic anhydrase I inhibitor | 0.06 0.035 CID_10446031 | CID_10446031 | |
| 0.027 | 0.093 | 0.126 | Protein 50S ribosomal subunit inhibitor | 0.126 0.009 CID_101649831 | CID_101649831 | |
| 0.009 | 0.079 | 0.02 | Corticosteroid-like | 0.02 0.018 CID_101649831 | CID_101649831 | |
| 0.02 | 0.098 | 0.064 | Phosphorylase inhibitor | 0.064 0.023 CID_101649831 | CID_101649831 | |
| 0.026 | 0.105 | 0.052 | Microtubule stabilization | 0.052 0.025 CID_101649831 | CID_101649831 | |
| 0.034 | 0.113 | 0.068 | HIV-1 reverse transcriptase inhibitor | 0.068 0.051 CID_10446031 | CID_10446031 | |
| 0.061 | 0.144 | 0.085 | Interleukin 5 antagonist | 0.085 0.064 CID_101649831 | CID_101649831 | |
| 0.076 | 0.166 | 0.337 | Cell adhesion inhibitor | 0.337 0.008 CID_101649831 | CID_101649831 | |
| 0.017 | 0.114 | 0.039 | Toll-Like receptor 4 agonist | 0.039 0.005 CID_10446031 0.037 0.006 CID_101649831 | CID_10446031 | |
| 0.051 | 0.152 | 0.184 | Cell adhesion molecule inhibitor | 0.184 0.011 CID_101649831 | CID_101649831 | |
| 0.026 | 0.131 | 0.386 | Selectin antagonist | 0.267 0.007 CID_10446031 0.386 0.003 CID_101649831 | CID_101649831 | |
| 0.012 | 0.119 | 0.138 | NMDA 2D receptor antagonist | 0.138 0.003 CID_10446031 | CID_10446031 | |
| 0.007 | 0.114 | 0.037 | Squalene synthetase inhibitor | 0.037 0.019 CID_101649831 | CID_101649831 | |
| 0.068 | 0.181 | 0.357 | Thrombolytic | 0.226 0.041 CID_10446031 0.357 0.016 CID_101649831 | CID_101649831 | |
| 0.036 | 0.164 | 0.113 | Histone deacetylase stimulant | 0.113 0.021 CID_101649831 | CID_101649831 | |
| 0.036 | 0.164 | 0.113 | Histone deacetylase SIRT1 stimulant | 0.113 0.021 CID_101649831 | CID_101649831 | |
| 0.01 | 0.158 | 0.064 | Protein 30S ribosomal subunit inhibitor | 0.064 0.005 CID_101649831 | CID_101649831 | |
| 0.01 | 0.159 | 0.077 | Factor Xa inhibitor | 0.077 0.019 CID_10446031 | CID_10446031 | |
| 0.026 | 0.181 | 0.127 | Factor IXa inhibitor | 0.127 0.005 CID_10446031 0.102 0.009 CID_101649831 | CID_10446031 | |
| 0.019 | 0.203 | 0.061 | H+/K+-transporting ATPase inhibitor | 0.061 0.024 CID_10446031 | CID_10446031 | |
| 0.099 | 0.287 | 0.151 | CC chemokine 6 receptor antagonist | 0.151 0.021 CID_101649831 | CID_101649831 | |
| 0.048 | 0.248 | 0.149 | Transcription factor NF kappa B stimulant | 0.149 0.016 CID_101649831 | CID_101649831 | |
| 0.017 | 0.222 | 0.083 | Antibiotic Aminoglycoside-like | 0.083 0.004 CID_101649831 | CID_101649831 | |
| 0.007 | 0.214 | 0.069 | Dopamine D2 agonist | 0.069 0.017 CID_10446031 | CID_10446031 | |
| 0.034 | 0.251 | 0.134 | DNA intercalator | 0.134 0.05 CID_101649831 | CID_101649831 | |
| 0.016 | 0.27 | 0.319 | NMDA 2B receptor antagonist | 0.319 0.004 CID_10446031 | CID_10446031 | |
| 0.041 | 0.356 | 0.405 | Dual specificity phosphatase 3 inhibitor | 0.405 0.013 CID_10446031 | CID_10446031 | |
| 0.042 | 0.358 | 0.41 | Dual specificity phosphatase inhibitor | 0.41 0.013 CID_10446031 | CID_10446031 | |
| 0.013 | 0.33 | 0.968 | Cholecystokinin B agonist | 0.968 0.001 CID_10446031 | CID_10446031 | |
| 0.078 | 0.441 | 0.421 | Immunomodulator | 0.421 0.038 CID_101649831 | CID_101649831 | |
| 0.024 | 0.438 | 0.26 | Multidrug resistance-associated protein 1 inhibitor | 0.26 0.005 CID_10446031 0.123 0.045 CID_101649831 | CID_10446031 | |
| 0.004 | 0.494 | 0.853 | Cholecystokinin A agonist | 0.853 0.001 CID_10446031 | CID_10446031 | |
| 0.034 | 0.536 | 0.082 | T cell inhibitor | 0.082 0.057 CID_101649831 | CID_101649831 | |
| 0.041 | 0.543 | 0.372 | Angiogenesis inhibitor | 0.372 0.062 CID_10446031 | CID_10446031 | |
| 0.003 | 0.514 | 0.869 | Cholecystokinin agonist | 0.869 0.001 CID_10446031 | CID_10446031 | |
| 0.011 | 0.545 | 0.115 | Thrombin inhibitor | 0.115 0.019 CID_10446031 | CID_10446031 | |
| 0.017 | 0.573 | 0.569 | Anticoagulant | 0.569 0.007 CID_10446031 0.229 0.044 CID_101649831 | CID_10446031 | |
| 0.004 | 0.579 | 0.502 | Cholecystokinin antagonist | 0.502 0.003 CID_10446031 | CID_10446031 | |
| 0.003 | 0.61 | 0.487 | Cholecystokinin B antagonist | 0.487 0.003 CID_10446031 | CID_10446031 | |
| 0.003 | 0.617 | 0.576 | Cholecystokinin A antagonist | 0.576 0.003 CID_10446031 | CID_10446031 | |
| 0.003 | 0.791 | 0.036 | Factor XI inhibitor | 0.036 0.02 CID_10446031 | CID_10446031 | Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |